Muscular Disorder TRIZ Cases
- Spectroscopic evaluation of edible oil using profiles
See how near-infrared reflectance spectroscopy enables real-time in situ evaluation of edible o
- Near-Infrared Spectroscopy for In-Situ Edible Oil Quality Monitoring
See how near-infrared spectroscopy transforms reflectance data into real-time oil quality metri
- Near-Infrared Spectroscopy for In Situ Edible Oil Quality Monitoring
See how near-infrared spectroscopy replaces bench analysis to monitor frying oil quality in rea
- MSC Purification by Centrifugal Filtration for Low BSA Aggregation
Centrifugal filtration purifies MSC compositions by lowering residual BSA and aggregates while preserving viability for safer IV use.
- Rare Ginsenoside Ginseng Extract via Enzymatic Hydrolysis
Enzymatic hydrolysis with β-glucosidase and heat treatment raises rare ginsenoside yield while avoiding harsh, unstable acid processing.
- HMGB1 Polypeptide Engineering for Inflammation-Free Tissue Regeneration
A modified HMGB1 polypeptide preserves CXCL12-CXCR4 regenerative signaling while blocking RAGE, TLR-2, and TLR-4 inflammation.
- Cachexia Combination Therapy for Immune Disorder Correction
A cachexia regimen combining (R)-ketorolac with an immunosuppressive agent corrects immune imbalance, increases body weight, and prolongs survival.
- Selective Myostatin Antibody Therapy for SMA Muscle Function
Selective inhibition of latent myostatin with apitegromab helps address SMA muscle atrophy and extend motor function gains alongside SMN therapy.
- NMD670 Composition for Myasthenia Gravis Neuromuscular Transmission
CIC-1 channel inhibition with NMD670 improves neuromuscular transmission in myasthenia gravis while avoiding limits of immunosuppressive therapy.
- Myogenic Progenitor Cell Therapy for Anal Sphincter Regeneration
Targeted myogenic progenitor cell injections improve anal sphincter regeneration and reduce incontinence episodes in selected patients.
- PDE7 Inhibitor Therapy for Chronic Fatigue Energy Imbalance
Raising cAMP with PDE7 inhibitors helps restore ionic balance and mitochondrial function to relieve chronic fatigue and exertional intolerance.
- Antibody-Oligonucleotide Complexes for Targeted DUX4 Silencing
An anti-TfR1 antibody carrier improves muscle delivery of DUX4-targeting oligonucleotides while maintaining formulation stability for FSHD treatment.
- ITGA7-Targeted Muscle Cell Cargo Delivery for Muscular Dystrophy
An ITGA7-binding carrier directs siRNA, shRNA, ASO, or drugs to muscle cells to modulate degeneration pathways in muscular dystrophy.
- ActRII-Binding Proteins for Targeted Receptor Signaling Blockade
Specific ActRII-binding proteins block ligand binding and downstream phosphorylation to treat muscle wasting, fibrosis, metabolic disease, and cancer.